Businessworld

Zydus Lifesciences Gets Two Approvals From USFDA For Silodosin, Pregabalin Capsules

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to market Silodosin Capsules, 4 mg and 8 mg. The company also received the final approval to ...
Monthly Prescribing Reference

Rapaflo available for benign prostatic hyperplasia (BPH)

RAPAFLO (Silodosin) 4mg, 8mg capsules by Watson Watson has launched Rapaflo (silodosin capsules), a selective alpha-1 adrenergic receptor antagonist, for the treatment of the signs and symptoms of ...
Medscape

Silodosin Shows Promise for Male Pelvic Pain Condition

May 19, 2011 (Washington, DC) — Treatment with the highly selective alpha blocker silodosin seems to improve symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), according to phase ...
FierceBiotech

Press Release: Watson Pharmaceuticals Announces Positive Phase 3 Results On Silodosin

Watson Pharmaceuticals Announces Positive Phase 3 Study Results On Silodosin For Treatment Of Benign Prostatic Hyperplasia CORONA, Calif., Jan. 16 -- Watson Pharmaceuticals, Inc., a leading specialty ...
Nature

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH

If we assume that the efficacy of silodosin and its propensity to cause abnormal ejaculation are both attributable to the selective blockade of α 1a-receptors, it is reasonable to hypothesize that ...